The Medical Team at Anaveon is responsible for overseeing clinical development and medical strategy for IL-2 complexes that selectively enhance effector T cell functions. They design and manage clinical trials, analyze data, and ensure regulatory compliance to bring innovative therapies to market effectively and safely.